【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 14
2 Introduction 15
2.1 Spinal Non-Fusion Overview 15
3 Products under Development 16
3.1 Spinal Non-Fusion – Pipeline Products by Stage of Development 16
3.2 Spinal Non-Fusion – Pipeline Products by Segment 17
3.3 Spinal Non-Fusion – Pipeline Products by Territory 18
3.4 Spinal Non-Fusion – Pipeline Products by Regulatory Path 19
3.5 Spinal Non-Fusion – Pipeline Products by Estimated Approval Date 20
3.6 Spinal Non-Fusion – Ongoing Clinical Trials 21
4 Spinal Non-Fusion – Pipeline Products under Development by Companies 22
4.1 Spinal Non-Fusion Companies – Pipeline Products by Stage of Development 22
4.2 Spinal Non-Fusion – Pipeline Products by Stage of Development 25
5 Spinal Non-Fusion Companies and Product Overview 28
5.1 ALCeraX Medizintechnik GmbH Company Overview 28
5.1.1 ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.2 Alphatec Holdings, Inc. Company Overview 29
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Amedica Corporation Company Overview 32
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Apollo Implants LLC Company Overview 35
5.4.1 Apollo Implants LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 ARO Medical, LLC Company Overview 36
5.5.1 ARO Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.6 Arthro Kinetics AG Company Overview 37
5.6.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 37
5.7 Artimplant AB Company Overview 38
5.7.1 Artimplant AB Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Ascendx Spine, Inc. Company Overview 42
5.8.1 Ascendx Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 AxioMed Spine Corporation Company Overview 43
5.9.1 AxioMed Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Baxano Surgical Inc Company Overview 48
5.10.1 Baxano Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Chi2Gel Ltd. Company Overview 52
5.11.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 City University London Company Overview 53
5.12.1 City University London Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Covexus Medical Technologies, LLC Company Overview 54
5.13.1 Covexus Medical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.14 Crocker Spinal Technologies, Inc. Company Overview 55
5.14.1 Crocker Spinal Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 CryoLife, Inc. Company Overview 57
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Curtin University Company Overview 59
5.16.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 DePuy Companies Company Overview 60
5.17.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 Disc Motion Technologies Company Overview 64
5.18.1 Disc Motion Technologies Pipeline Products & Ongoing Clinical Trials Overview 64
5.19 Elite Surgical Supplies (Pty) Limited Company Overview 68
5.19.1 Elite Surgical Supplies (Pty) Limited Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 FlexSIS Ltd. Company Overview 69
5.20.1 FlexSIS Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
5.21 Flexuspine, Inc. Company Overview 70
5.21.1 Flexuspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.22 Gentis Inc. Company Overview 71
5.22.1 Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.23 Globus Medical, Inc. Company Overview 74
5.23.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.24 Hydrospine, Inc. Company Overview 81
5.24.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 IB Medical AB Company Overview 82
5.25.1 IB Medical AB Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 Innovia LLC Company Overview 83
5.26.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Integra LifeSciences Holdings Corporation Company Overview 84
5.27.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Jemo Spine, LLC. Company Overview 86
5.28.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.29 LDR Holding Corporation Company Overview 87
5.29.1 LDR Holding Corporation Pipeline Products & Ongoing Clinical Trials Overview 87
5.30 Medical University of South Carolina Company Overview 89
5.30.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 Medicrea International SA Company Overview 90
5.31.1 Medicrea International SA Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Medtronic plc Company Overview 95
5.32.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 95
5.33 MI4 Spine, LLC Company Overview 100
5.33.1 MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 100
5.34 MicroPort Scientific Corporation Company Overview 101
5.34.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 101
5.35 MiMedx Group, Inc Company Overview 103
5.35.1 MiMedx Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Nano Interface Technology, Inc. Company Overview 105
5.36.1 Nano Interface Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 NeuroPro Technologies, Inc. Company Overview 106
5.37.1 NeuroPro Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Nexgen Spine Inc. Company Overview 107
5.38.1 Nexgen Spine Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 NLT Spine Company Overview 109
5.39.1 NLT Spine Pipeline Products & Ongoing Clinical Trials Overview 109
5.40 NuVasive, Inc. Company Overview 113
5.40.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.41 Orthonex LLC Company Overview 119
5.41.1 Orthonex LLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.42 Paramount Surgicals Company Overview 122
5.42.1 Paramount Surgicals Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Precision Spine, Inc. Company Overview 125
5.43.1 Precision Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.44 Premia Spine, Ltd. Company Overview 126
5.44.1 Premia Spine, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Ranier Technology Limited Company Overview 129
5.45.1 Ranier Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Raymedica, LLC Company Overview 132
5.46.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.47 RE Spine, LLC Company Overview 134
5.47.1 RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 134
5.48 Reduction Technologies, Inc. Company Overview 135
5.48.1 Reduction Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.49 Replication Medical, Inc. Company Overview 136
5.49.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.50 Resoimplant GmbH (Inactive) Company Overview 137
5.50.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 S14 Implants Company Overview 138
5.51.1 S14 Implants Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 SeaSpine, Inc. (Inactive) Company Overview 139
5.52.1 SeaSpine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 Simpirica Spine, Inc. Company Overview 140
5.53.1 Simpirica Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.54 Simplify Medical, Inc. Company Overview 142
5.54.1 Simplify Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Smart Disc, Inc. Company Overview 143
5.55.1 Smart Disc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 Spinal Kinetics Inc. Company Overview 144
5.56.1 Spinal Kinetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Spinalcyte Llc Company Overview 149
5.57.1 Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 SpinalMotion, Inc. Company Overview 150
5.58.1 SpinalMotion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 SpinalVu Inc Company Overview 157
5.59.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 157
5.60 Spine Smith, LP Company Overview 158
5.60.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 158
5.61 Spine Wave, Inc. Company Overview 160
5.61.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.62 Spine21 Ltd. Company Overview 163
5.62.1 Spine21 Ltd. Pipeline Products & Ongoing Clinical Trials Overview 163
5.63 SpineLab AG Company Overview 164
5.63.1 SpineLab AG Pipeline Products & Ongoing Clinical Trials Overview 164
5.64 Stryker Corporation Company Overview 165
5.64.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 165
5.65 Synergy Disc Replacement, Inc. Company Overview 167
5.65.1 Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview 167
5.66 Synthes, Inc. Company Overview 169
5.66.1 Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.67 Takiron Co., Ltd. Company Overview 170
5.67.1 Takiron Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 170
5.68 TrueMotion Spine, Inc. Company Overview 172
5.68.1 TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 172
5.69 University of Colorado Company Overview 174
5.69.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 174
5.70 University of South Florida Company Overview 175
5.70.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 175
5.71 Vertebral Technologies, Inc. Company Overview 176
5.71.1 Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.72 Weill Cornell Medical College Company Overview 180
5.72.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 180
5.73 X-spine Systems, Inc. Company Overview 181
5.73.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.74 Zimmer Biomet Holdings, Inc. Company Overview 182
5.74.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
6 Spinal Non-Fusion – Recent Developments 188
7 Appendix 226
7.1 Methodology 226
7.2 About GlobalData 228
7.3 Contact Us 229
7.4 Disclaimer 229
【レポート販売概要】
■ タイトル：世界における脊椎非固定デバイスの製品パイプライン動向2015■ 英文：Spinal Non-Fusion - Pipeline Review, 2015
■ 発行日：2015年9月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0066EPD
■ 調査対象地域：グローバル
- IoTマネジードサービスの世界市場予測（～2021年）Growing inclination toward cost-efficient managed services is expected to drive the growth of the IoT managed services marketThe IoT managed services market size is expected to grow from USD 21.85 billion in 2016 to USD 79.60 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 29.5% during the period 2016–2021. The major drivers for the upsurge in demand for the IoT managed services market …
- ソフトウェア定義ストレージ（SDS）の世界市場分析：用途別（BFSI、教育、ITサービス、政府、製造、ヘルスケア）、企業規模別（中小企業、大企業）、セグメント予測The software defined storage (SDS) market size is expected to reach USD 17,461.9 million by 2024, according to a new study conducted by Grand View Research, Inc. The emergence of the Big Data technology is anticipated to impel growth in the global softwaredefined storagemarket. Technological propagation, coupled with benefits such as high flexibility and cloud storage,is instrumental in keeping th …
- 機能性流体の世界市場：プロセス油、作動液/トランスミッション液、金属加工油、伝熱流体The global functional fluids market is projected to be worth USD 42.2 Billion by 2020, registering a CAGR of 4.5% between 2015 and 2020. The growth of market is primarily driven by the processing industries for manufacturing the finished goods. The massive industrial growth in Asia-Pacific and Africa drive the functional fluid market. Moreover, strong OEM recommendation to use high-performance fun …
- ポリアリルスルホンの世界市場：PSU、PEI、PESU、PPSUPolyarylsulfone Market 2015-2019 Covering: This market research report presents a detailed segmentation of the global polyarylsulfone market by type (PSU, PEI, PESU, and PPSU) and by application (medical, automobile, electrical and electronics, and mechanical engineering). It provides a market share analysis of its key regions, including APAC, Europe, North America, and ROW. Key findings also incl …
- 量子ドットの世界市場予測（～2023年）：QD医療機器、QD太陽電池、QD光検知器、QDセンサ、QDレーザー、QD照明、電池、エネルギー貯蔵システム、QDトランジスタ、QDタグThe quantum dots market is estimated to grow from USD 2.57 Billion in 2018 to reach USD 8.47 Billion by 2023, at a CAGR of 26.97% during the forecast period. The market growth is mainly driven by the factors such as the increasing demand for quantum dots in high-quality display devices, growing implementation of quantum dots in numerous applications due to their miniature property, and rising adop …
- 乳房生検の世界市場2017-2021About Breast BiopsyA breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer. Technavio’s analysts forecast the global breas …
- スマート水管理ソリューションの世界市場：先進水道メーター、ネットワークモニタリング、圧力管理、分析、メーターデータ管理The Smart Water Management (SWM) market has witnessed a major growth over recent years with the integration of ICT in different verticals, and increasing adoption of technologies. This has helped in proper water management and reduction of Non-Revenue Water (NRW) loss due to leaks, thefts, pipe bursts, and metering errors. With the increasing demand of SWM solutions, key players are also investing …
- グラント管理ソフトウェアの世界市場予測（～2024年）Growing demand to automate the grant process and need to ensure regulatory compliance with advanced reporting to drive the overall growth of the grant management software market The global grant management software market size is expected to grow from USD 1.1 billion in 2019 to USD 1.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.5% during the forecast period. The grant managemen …
- 主要先進国における全身性乾癬治療薬市場（～2020）Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Summary GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially o …
- 保護継電器の世界市場2016-2020About Relays A device that senses the quantity of current flowing in the supply lines before entering the power system of the equipment or motor can prevent the motor from damage. A relay is one such electromechanical device that is actuated by electrical current. In a relay, the current flowing in one circuit causes the opening and closing of another circuit. Due to the simplicity, long life, and …
- 世界の植物成長調整剤(PGR)市場2015The Global Plant Growth Regulators (PGR) Industry Report 2015 is a professional and in-depth study on the current state of the Plant Growth Regulators (PGR) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Plant Growth Regulators (PGR) market analysis is provided for the international markets inclu …
- サファイア半導体の世界市場2016-2020About Sapphires Sapphire is a versatile material that is used in LEDs and consumer electronics. It is used in a wide range of end markets due to attributes such as durability, light transmission, chemical inertness, thermal insulation, hardness, and resistance to physical damage and chemical erosion. Technavio’s analysts forecast the global sapphire semiconductor market to grow at a CAGR of 11.25% …
- 果糖の世界市場分析：製品別（高果糖コーンシロップ、フルクトースシロップ、果糖固形分）、用途別（飲料、加工食品、乳製品、菓子、製パン･穀物）、セグメント予測、2014-2025The global fructose market is expected to reach USD 5.68 billion by 2025, according to a new report by Grand View Research, Inc. The growing consumption of low-calorie foods and beverages owing to the rising awareness regarding the adverse effects of sugar is expected to boost market demand.Fructose is majorly used in the production of nutrition bars, soft moist cookies, pourable frozen juice conc …
- プラスチック加工機械の世界市場：射出成形機、押出成形機、ブロー成形機About Plastic Processing Machinery Plastic processing machines are used to perform variety of methods to convert plastic materials in the form of pellets, granules, powders, sheets, and fluids into formed shapes or parts. After formation of parts, various ancillary operations such as welding, adhesive bonding, machining, and surface decoration are performed to produce the final products. The proce …
- 高コレステロール血症治療薬の世界市場2016-2020About Hypercholesterolemia Hypercholesterolemia is characterized by high levels of total cholesterol and LDL-C in the blood. High cholesterol levels can cause CVDs such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL.Blood cholesterol contains individual components such as LDL-C and HDL-C. LDL carries cholesterol to the body and HDL removes cholesterol …
